CohBar, Inc. (CWBR) Q3 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tuhura Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.711 good afternoon my name is matt and i will be your conference operator for today at this 00:00:04.711 -- 00:00:09.233 time i would like to welcome everyone to cobar's third quarter 2022 financial results 00:00:09.233 -- 00:00:14.395 conference call all lines have been placed on mute to eliminate background noise should 00:00:14.395 -- 00:00:18.257 you need assistance please signal conference specialist by pressing the star key followed 00:00:18.257 -- 00:00:24.240 by zero after today's presentation there will be an opportunity to ask questions 00:00:24.240 -- 00:00:28.982 to ask a question you may press star then one on a touch tone phone to withdraw your 00:00:28.982 -- 00:00:33.880 question please press star then two. Please note this event is being recorded. 00:00:33.880 -- 00:00:38.962 I would now like to turn the conference over to Jordan Tarazi, Director of Investor Relations 00:00:38.962 -- 00:00:41.224 at COBAR. Please go ahead. 00:00:41.224 -- 00:00:45.726 Thank you, Operator, and thank you, everyone, for joining COBAR's third quarter 2022 00:00:45.726 -- 00:00:49.568 financial results conference call. Joining me on today's call is Dr. 00:00:49.568 -- 00:00:52.849 Joe Surrett, COBAR's Chief Executive Officer, Jeff B. 00:00:52.849 -- 00:00:55.731 Uno, COBAR's Chief Financial Officer, and Dr. 00:00:55.731 -- 00:00:59.062 Kent Grindstaff, Senior Vice President of Research. 00:00:59.062 -- 00:01:03.225 Following our collective remarks, we will conclude with Q&A, at which time Dr. 00:01:03.225 -- 00:01:08.469 Nick Vlahakis, COBAR's Acting Chief Medical Officer, will also join us. 00:01:08.469 -- 00:01:13.013 COBAR's financial results press release was issued earlier today and may be downloaded 00:01:13.013 -- 00:01:15.755 from o...